國立虎尾科技大學 |

Multidisciplinary Approach to Neurofibromatosis Type 1

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Multidisciplinary Approach to Neurofibromatosis Type 1/ edited by Gianluca Tadini, Eric Legius, Hilde Brems.
其他作者:	Brems, Hilde.
面頁冊數:	XII, 313 p. 66 illus., 55 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	General Practice / Family Medicine. -
電子資源:	https://doi.org/10.1007/978-3-319-92450-2
ISBN:	9783319924502

Multidisciplinary Approach to Neurofibromatosis Type 1
Multidisciplinary Approach to Neurofibromatosis Type 1[electronic resource] /edited by Gianluca Tadini, Eric Legius, Hilde Brems. - 1st ed. 2020. - XII, 313 p. 66 illus., 55 illus. in color.online resource.

1. Epidemiology of Neurofibromatosis Type 1 -- 2. Genetics and Pathway in Neurofibromatosis Type 1 -- 3. Molecular Diagnosis for NF1 -- 4. Diagnosis in NF1, Old and New -- 5. Clinical Features of NF1 in the Skin -- 6. Ocular Manifestations in Neurofibromatosis Type 1 -- 7. Skeletal Manifestations in NF1 -- 8. NF1 in Other Organs -- 9. Genomics of Peripheral Nerve Sheath Tumors Associated to Neurofibromatosis Type 1 -- 10. Mechanotransduction and Nf1 Loss--Partner in Crime: New Hints for Neurofibroma Genesis -- 11. Diagnosis and Management of Benign Nerve Sheath Tumors in NF1: Evolution from Plexiform to Atypical Neurofibroma and Novel Treatment Approaches -- 12. Diagnosis and Management of Malignant Tumors in NF1: Evolution from Atypical Neurofibromas to Malignant Peripheral Nerve Sheath Tumors and Treatment Options -- 13. Neurological Complications in NF -- 14. Learning Disabilities and Behavior in Neurofibromatosis Type 1 Patients -- 15. Mosaic NF1 -- 16. Legius Syndrome, Other Café -au-lait Diseases and Differential Diagnosis of NF1 -- 17. Cancer Risk and Spectrum in Individuals with RASopathies -- 18. Therapeutical Approaches for NF1 -- 19. Medical Follow up in Neurofibromatosis Type 1 -- 20. Brief Notes on Pregnancy, Prenatal Diagnosis and Preimplantation Procedures in NF1 -- 21. Proposal of New Diagnostic Criteria.

This volume offers an update of the clinical signs, diagnostic criteria (including molecular diagnosis) and targeted therapies for a particular type of genodermatosis, providing a handy and unique tool for early diagnosis. In recent years, our understanding of genodermatosis and neurocutaneous syndromes has increased, but although Type 1 Neurofibromatosis (NF1) is the most common neuroectodermal disorder and involves a large number of patients and medical disciplines, this syndrome remains underestimated, often misdiagnosed thus leading to inaccurate treament. The literature on the molecular and pathogenetic aspects is ample, but current clinical approaches, classification, diagnostic criteria and treatment protocols are outdated, creating difficulties in early diagnosis and treatment. As such, a chapter is devoted renewing current diagnostic criteria; it includes clinical and molecular data, to offer a sound, updated discussion basis for a consensus conference. NF1 is a “time-dependent” disorder, meaning that the onset of clinical signs are closely linked to patient age and the book discusses this particularly neglected aspect extensively, as well as the latest molecular diagnosis techniques, which are highly sensitive have not been included in the diagnostic criteria. It also explains the role of the RAS-MAPK pathway and genotype-phenotype correlations. In addition it explores new concepts concerning the pathogenesis of neurofibromas and other hamarthomas and their relevance for a modern therapeutical approach with targeted molecular drugs, as well as newly discovered aspects of NF1 in all internal organs, together with their diagnostic counterparts. A chapter on mosaic neurofibromatosis is also included. There is a particular focus on differential diagnosis (i.e. other diseases with café-au-lait macules), and the recently described Legius syndrome will be presented directly by Prof Eric Legius. All chapters are easy-to-understand, up-to-date, comprehensive and concise tools and are intended for a wide range of professionals involved with genetic disorders of the skin and neurocutaneous diseases: dermatologists, pediatricians, neurologists, oncologists and general practitioners.

ISBN: 9783319924502

Standard No.: 10.1007/978-3-319-92450-2doiSubjects--Topical Terms:

593966
General Practice / Family Medicine.

LC Class. No.: RL1-803

Dewey Class. No.: 616.5

Multidisciplinary Approach to Neurofibromatosis Type 1
LDR:04876nam a22003855i 4500 001 1020155
003 DE-He213
005 20200703112901.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783319924502 $9 978-3-319-92450-2
024 7 $a 10.1007/978-3-319-92450-2 $2 doi
035 $a 978-3-319-92450-2
050 4 $a RL1-803
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.5 $2 23
245 1 0 $a Multidisciplinary Approach to Neurofibromatosis Type 1 $h [electronic resource] / $c edited by Gianluca Tadini, Eric Legius, Hilde Brems.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a XII, 313 p. 66 illus., 55 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Epidemiology of Neurofibromatosis Type 1 -- 2. Genetics and Pathway in Neurofibromatosis Type 1 -- 3. Molecular Diagnosis for NF1 -- 4. Diagnosis in NF1, Old and New -- 5. Clinical Features of NF1 in the Skin -- 6. Ocular Manifestations in Neurofibromatosis Type 1 -- 7. Skeletal Manifestations in NF1 -- 8. NF1 in Other Organs -- 9. Genomics of Peripheral Nerve Sheath Tumors Associated to Neurofibromatosis Type 1 -- 10. Mechanotransduction and Nf1 Loss--Partner in Crime: New Hints for Neurofibroma Genesis -- 11. Diagnosis and Management of Benign Nerve Sheath Tumors in NF1: Evolution from Plexiform to Atypical Neurofibroma and Novel Treatment Approaches -- 12. Diagnosis and Management of Malignant Tumors in NF1: Evolution from Atypical Neurofibromas to Malignant Peripheral Nerve Sheath Tumors and Treatment Options -- 13. Neurological Complications in NF -- 14. Learning Disabilities and Behavior in Neurofibromatosis Type 1 Patients -- 15. Mosaic NF1 -- 16. Legius Syndrome, Other Café -au-lait Diseases and Differential Diagnosis of NF1 -- 17. Cancer Risk and Spectrum in Individuals with RASopathies -- 18. Therapeutical Approaches for NF1 -- 19. Medical Follow up in Neurofibromatosis Type 1 -- 20. Brief Notes on Pregnancy, Prenatal Diagnosis and Preimplantation Procedures in NF1 -- 21. Proposal of New Diagnostic Criteria.
520 $a This volume offers an update of the clinical signs, diagnostic criteria (including molecular diagnosis) and targeted therapies for a particular type of genodermatosis, providing a handy and unique tool for early diagnosis. In recent years, our understanding of genodermatosis and neurocutaneous syndromes has increased, but although Type 1 Neurofibromatosis (NF1) is the most common neuroectodermal disorder and involves a large number of patients and medical disciplines, this syndrome remains underestimated, often misdiagnosed thus leading to inaccurate treament. The literature on the molecular and pathogenetic aspects is ample, but current clinical approaches, classification, diagnostic criteria and treatment protocols are outdated, creating difficulties in early diagnosis and treatment. As such, a chapter is devoted renewing current diagnostic criteria; it includes clinical and molecular data, to offer a sound, updated discussion basis for a consensus conference. NF1 is a “time-dependent” disorder, meaning that the onset of clinical signs are closely linked to patient age and the book discusses this particularly neglected aspect extensively, as well as the latest molecular diagnosis techniques, which are highly sensitive have not been included in the diagnostic criteria. It also explains the role of the RAS-MAPK pathway and genotype-phenotype correlations. In addition it explores new concepts concerning the pathogenesis of neurofibromas and other hamarthomas and their relevance for a modern therapeutical approach with targeted molecular drugs, as well as newly discovered aspects of NF1 in all internal organs, together with their diagnostic counterparts. A chapter on mosaic neurofibromatosis is also included. There is a particular focus on differential diagnosis (i.e. other diseases with café-au-lait macules), and the recently described Legius syndrome will be presented directly by Prof Eric Legius. All chapters are easy-to-understand, up-to-date, comprehensive and concise tools and are intended for a wide range of professionals involved with genetic disorders of the skin and neurocutaneous diseases: dermatologists, pediatricians, neurologists, oncologists and general practitioners.
650 2 4 $a General Practice / Family Medicine. $3 593966
650 2 4 $a Oncology. $3 593951
650 2 4 $a Neurology. $3 593894
650 2 4 $a Human Genetics. $3 593893
650 0 $a General practice (Medicine). $3 1253458
650 0 $a Oncology . $3 1253469
650 0 $a Neurology . $3 1253459
650 0 $a Human genetics. $3 596505
650 0 $a Pediatrics. $3 644839
650 0 $a Dermatology. $3 669082
700 1 $a Brems, Hilde. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1315567
700 1 $a Legius, Eric. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1315566
700 1 $a Tadini, Gianluca. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1315565
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319924496
776 0 8 $i Printed edition: $z 9783319924519
856 4 0 $u https://doi.org/10.1007/978-3-319-92450-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)